Amplitude Surgical SAS (AMPLI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Amplitude Surgical SAS (AMPLI) has a cash flow conversion efficiency ratio of 0.029x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.77 Million ≈ $3.24 Million USD) by net assets (€94.70 Million ≈ $110.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Amplitude Surgical SAS's balance sheet to measure how much of total assets are equity-financed.
Amplitude Surgical SAS - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Amplitude Surgical SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Amplitude Surgical SAS cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Amplitude Surgical SAS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amplitude Surgical SAS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Patec Precision Industry Co Ltd
TW:2236
|
0.001x |
|
Guangzhou Shangpin Home Collection Co Ltd
SHE:300616
|
0.018x |
|
M1 Kliniken AG
XETRA:M12
|
0.129x |
|
Shandong Huapeng Glass Co Ltd
SHG:603021
|
0.035x |
|
Colonial Coal International Corp
V:CAD
|
-0.023x |
|
Anhui Shiny Electronic Technology Company Limited
SHE:300956
|
N/A |
|
INTEKPLUS Co. Ltd
KQ:064290
|
0.035x |
|
Zaggle Prepaid Ocean Services Limited
NSE:ZAGGLE
|
-0.024x |
Annual Cash Flow Conversion Efficiency for Amplitude Surgical SAS (2011–2024)
The table below shows the annual cash flow conversion efficiency of Amplitude Surgical SAS from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see AMPLI stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | €95.82 Million ≈ $112.02 Million |
€4.04 Million ≈ $4.73 Million |
0.042x | -50.07% |
| 2023-06-30 | €95.81 Million ≈ $112.02 Million |
€8.10 Million ≈ $9.47 Million |
0.084x | -44.36% |
| 2022-06-30 | €52.57 Million ≈ $61.46 Million |
€7.98 Million ≈ $9.33 Million |
0.152x | +268.42% |
| 2021-06-30 | €56.87 Million ≈ $66.48 Million |
€2.34 Million ≈ $2.74 Million |
0.041x | -76.40% |
| 2020-06-30 | €70.91 Million ≈ $82.90 Million |
€12.38 Million ≈ $14.48 Million |
0.175x | +81.15% |
| 2019-06-30 | €85.50 Million ≈ $99.95 Million |
€8.24 Million ≈ $9.64 Million |
0.096x | +1.63% |
| 2018-06-30 | €94.68 Million ≈ $110.69 Million |
€8.98 Million ≈ $10.50 Million |
0.095x | +265.03% |
| 2017-06-30 | €103.14 Million ≈ $120.58 Million |
€2.68 Million ≈ $3.13 Million |
0.026x | +54.47% |
| 2016-06-30 | €118.12 Million ≈ $138.09 Million |
€1.99 Million ≈ $2.32 Million |
0.017x | +112.09% |
| 2015-06-30 | €118.76 Million ≈ $138.84 Million |
€-16.53 Million ≈ $-19.33 Million |
-0.139x | -59.01% |
| 2014-06-30 | €22.31 Million ≈ $26.08 Million |
€-1.95 Million ≈ $-2.28 Million |
-0.088x | -1008.15% |
| 2013-06-30 | €20.44 Million ≈ $23.89 Million |
€197.00K ≈ $230.31K |
0.010x | +106.61% |
| 2012-06-30 | €22.40 Million ≈ $26.18 Million |
€-3.26 Million ≈ $-3.82 Million |
-0.146x | -8.89% |
| 2011-06-30 | €25.40 Million ≈ $29.69 Million |
€-3.40 Million ≈ $-3.97 Million |
-0.134x | -- |
About Amplitude Surgical SAS
Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-u… Read more